As of 2025-10-29, the Relative Valuation of Royalty Pharma PLC (RPRX) is 36.48 USD. This relative valuation is based on P/E multiples. With the latest stock price at 36.41 USD, the upside of Royalty Pharma PLC based on Relative Valuation is 0.2%.
The range of the Relative Valuation is 31.12 - 42.38 USD.
| Range | Selected | |
| Trailing P/E multiples | 17.8x - 21.6x | 19.4x |
| Forward P/E multiples | 20.5x - 24.5x | 22.6x |
| Fair Price | 31.12 - 42.38 | 36.48 |
| Upside | -14.5% - 16.4% | 0.2% |
| Date | P/E |
| 2025-10-29 | 20.92 |
| 2025-10-28 | 20.80 |
| 2025-10-27 | 21.29 |
| 2025-10-24 | 21.29 |
| 2025-10-23 | 21.05 |
| 2025-10-22 | 21.05 |
| 2025-10-21 | 21.41 |
| 2025-10-20 | 20.93 |
| 2025-10-17 | 21.14 |
| 2025-10-16 | 20.76 |
| 2025-10-15 | 20.67 |
| 2025-10-14 | 20.57 |
| 2025-10-13 | 20.25 |
| 2025-10-10 | 20.57 |
| 2025-10-09 | 20.65 |
| 2025-10-08 | 20.58 |
| 2025-10-07 | 20.62 |
| 2025-10-06 | 20.64 |
| 2025-10-03 | 20.61 |
| 2025-10-02 | 20.85 |
| 2025-10-01 | 20.75 |
| 2025-09-30 | 20.16 |
| 2025-09-29 | 20.14 |
| 2025-09-26 | 20.02 |
| 2025-09-25 | 19.94 |
| 2025-09-24 | 20.44 |
| 2025-09-23 | 20.70 |
| 2025-09-22 | 20.49 |
| 2025-09-19 | 20.70 |
| 2025-09-18 | 20.41 |
| 2025-09-17 | 20.36 |
| 2025-09-16 | 20.24 |
| 2025-09-15 | 20.08 |
| 2025-09-12 | 20.77 |
| 2025-09-11 | 20.97 |
| 2025-09-10 | 20.67 |
| 2025-09-09 | 20.85 |
| 2025-09-08 | 20.45 |
| 2025-09-05 | 20.61 |
| 2025-09-04 | 21.08 |
| 2025-09-03 | 20.94 |
| 2025-09-02 | 20.66 |
| 2025-08-29 | 20.56 |
| 2025-08-28 | 20.35 |
| 2025-08-27 | 20.60 |
| 2025-08-26 | 20.56 |
| 2025-08-25 | 20.56 |
| 2025-08-22 | 20.75 |
| 2025-08-21 | 20.74 |
| 2025-08-20 | 21.07 |